يعرض 1 - 20 نتائج من 295 نتيجة بحث عن '"Pintos‐Morell, Guillem"', وقت الاستعلام: 1.69s تنقيح النتائج
  1. 1
    Academic Journal
  2. 2
    Academic Journal
  3. 3
    Academic Journal

    المساهمون: Institut Català de la Salut, Casado E Rheumatology Department, Hospital Universitario Parc Taulí, Sabadell, Barcelona, Spain. Gómez-Alonso C Bone and Mineral Metabolism Clinical Management Unit, Hospital Universitario Central de Asturias, Oviedo, Spain. Pintos-Morell G Unitat de Malalties Metabòliques Hereditàries, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Bou-Torrent R Paediatric Rheumatology Unit, Hospital Sant Joan de Déu, Barcelona, Spain. Barreda-Bonis AC Paediatric Endocrinology Department, Hospital Universitario la Paz, Madrid, Spain. Torregrosa JV Department of Nephrology and Renal Transplant, Hospital Clínic de Barcelona, Barcelona, Spain. Chocrón-de-Benzaquen S Servei de Nefrologia Pediàtrica, Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    Relation: Orphanet Journal of Rare Diseases;18; https://doi.org/10.1186/s13023-023-02856-6; Casado E, Gómez-Alonso C, Pintos-Morell G, Bou-Torrent R, Barreda-Bonis AC, Torregrosa JV, et al. Transition of patients with metabolic bone disease from paediatric to adult healthcare services: current situation and proposals for improvement. Orphanet J Rare Dis. 2023 Aug 29;18:245.; https://hdl.handle.net/11351/10218

  4. 4
  5. 5
    Academic Journal
  6. 6
    Academic Journal
  7. 7
    Academic Journal

    وصف الملف: application/pdf

    Relation: Journal of clinical medicine; Vol. 10 (april 2021); https://ddd.uab.cat/record/255530; urn:10.3390/jcm10081664; urn:oai:ddd.uab.cat:255530; urn:pmcid:PMC8068937; urn:pmc-uid:8068937; urn:oai:pubmedcentral.nih.gov:8068937; urn:pmid:33924567; urn:oai:egreta.uab.cat:publications/ecf5f93b-46c9-4b08-81b4-c5a96d8a8d0b

  8. 8
    Academic Journal
  9. 9
    Academic Journal

    وصف الملف: application/pdf

    Relation: Ministerio de Economía y Competitividad PI15/01756; Instituto de Salud Carlos III PI18/00713; Ministerio de Economía y Competitividad CD14/00032; Agencia Estatal de Investigación PID2020-118730RB-I00; Ministerio de Economía y Competitividad CM16/00016; Ministerio de Economía y Competitividad CPII16/00004; Instituto de Salud Carlos III PI17/00011; Instituto de Salud Carlos III PI20/00114; Journal of clinical medicine; Vol. 10 (november 2021); https://ddd.uab.cat/record/282874; urn:10.3390/jcm10235520; urn:oai:ddd.uab.cat:282874; urn:pmcid:PMC8658563; urn:pmc-uid:8658563; urn:pmid:34884222; urn:oai:pubmedcentral.nih.gov:8658563

  10. 10
    Academic Journal

    المساهمون: Institut Català de la Salut, Carnicer-Cáceres C, Arranz-Amo JA, Cea-Arestin C Laboratori d'Errors Innats del Metabolisme, Laboratoris Clínics, Vall d’Hebron Hospital, Barcelona, Spain. Camprodon-Gomez M Servei de Medicina Interna, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Unitat de Malalties Metabòliques Hereditàries, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Moreno-Martinez D Servei de Medicina Interna, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Unitat de Malalties Metabòliques Hereditàries, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Lysosomal Storage Disorders Unit, Royal Free Hospital NHS Foundation Trust and University College London, London WC1E 6BT, UK. Lucas-Del-Pozo S Laboratori de Malalties Neurodegeneratives, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. Servei de Neurologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, London WC1N 3BG, UK. Moltó-Abad M Validació Funcional i Investigació Preclínica, Distribució de Fàrmacs i Grup d'Orientació, CIBIM-Nanomedicina, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), 08035 Barcelona, Spain. Tigri-Santiña A Unitat de Malalties Metabòliques Hereditàries, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Agraz-Pamplona I Servei de Nefrologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Rodriguez-Palomares JF Servei de Cardiologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Hernández-Vara J, Armengol-Bellapart M Laboratori de Malalties Neurodegeneratives, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. Servei de Neurologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Del-Toro-Riera M Unitat de Malalties Metabòliques Hereditàries, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Servei de Neurologia Pediàtrica, Unitat de Malalties Metabòliques Hereditàries, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Pintos-Morell G Unitat de Malalties Metabòliques Hereditàries, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Validació Funcional i Investigació Preclínica, Distribució de Fàrmacs i Grup d'Orientació, CIBIM-Nanomedicina, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    Relation: Journal of Clinical Medicine;10(8); https://doi.org/10.3390/jcm10081664; Carnicer-Cáceres C, Arranz-Amo JA, Cea-Arestin C, Camprodon-Gomez M, Moreno-Martinez D, Lucas-Del-Pozo S, et al. Biomarkers in Fabry Disease: Implications for Clinical Diagnosis and Follow-up. J Clin Med. 2021 Apr 13;10(8):1664.; https://hdl.handle.net/11351/6740; 000644476500001

  11. 11
    Academic Journal

    المساهمون: Institut Català de la Salut, Seras-Franzoso J, González P, Schwartz S Jr Drug Delivery & Targeting, CIBBIM-Nanomedicine, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Barcelona, Spain. Díaz-Riascos ZV, García-Aranda N, Mandaña M, Boullosa A, Mancilla S, Abasolo I Drug Delivery & Targeting, CIBBIM-Nanomedicine, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Barcelona, Spain. Functional Validation & Preclinical Research (FVPR), CIBBIM-Nanomedicine, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Corchero JL Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Barcelona, Spain. Institut de Biotecnologia i de Biomedicina (IBB) and Department of Genetics and Microbiology, Universitat Autònoma de Barcelona, Bellaterra, Spain. Grayston A, Rosell A Neurovascular Research Laboratory, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Moltó-Abad M, Pintos-Morell G Drug Delivery & Targeting, CIBBIM-Nanomedicine, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Division of Rare Diseases, Reference Center for Hereditary Metabolic Disorders (CSUR, XUEC, MetabERN, and CIBER-ER). Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    Relation: Journal of Extracellular Vesicles;10(5); info:eu-repo/grantAgreement/ES/PE2013-2016/PI18%2F00871; Seras‐Franzoso J, Díaz‐Riascos ZV, Corchero JL, González P, García‐Aranda N, Mandaña M, et al. Extracellular vesicles from recombinant cell factories improve the activity and efficacy of enzymes defective in lysosomal storage disorders. J Extracell Vesicles. 2021 Mar;10(5):e12058.; https://hdl.handle.net/11351/6205; 000632839300005

  12. 12
  13. 13
    Academic Journal

    مصطلحات موضوعية: Genética humana, Bioquímica

    Relation: Ballester-López, A., Linares-Pardo, I., Koehorst, E., Núñez-Manchón, J., Pintos-Morell, G., Coll-Cantí, J., Almendrote, M., Lucente, G., Arbex, A., Magaña, J. J., Murillo-Melo, N. M., Lucía, A., Monckton, D. G., Cumming, S. A., Ramos-Fransi, A., Martínez-Piñeiro, A., & Nogales-Gadea, G. (2020). The Need for Establishing a Universal CTG Sizing Method in Myotonic Dystrophy Type 1. Genes, 11(7), 757. https://doi.org/10.3390/genes11070757; http://hdl.handle.net/11268/9155

  14. 14
    Academic Journal
  15. 15
    Academic Journal
  16. 16
    Academic Journal

    وصف الملف: application/pdf

    Relation: Drug Design, Development and Therapy; Vol. 14 (june 2020), p. 2149-2158; https://ddd.uab.cat/record/252702; urn:10.2147/DDDT.S249433; urn:oai:ddd.uab.cat:252702; urn:pmcid:PMC7276893; urn:pmc-uid:7276893; urn:pmid:32581513; urn:oai:pubmedcentral.nih.gov:7276893; urn:articleid:11778881v14p2149; urn:oai:egreta.uab.cat:publications/26da13db-4c72-4df6-a99a-a8c2008dcd26

  17. 17
    Academic Journal

    وصف الملف: application/pdf

    Relation: Instituto de Salud Carlos III PI15-01756; Instituto de Salud Carlos III PI15-00558; Instituto de Salud Carlos III PI18-00713; Instituto de Salud Carlos III CD14-00032; Instituto de Salud Carlos III CPII19-00021; Instituto de Salud Carlos III CM16-00016; Agència de Gestió d'Ajuts Universitaris i de Recerca FI_B 01090; Agència de Gestió d'Ajuts Universitaris i de Recerca SGR1520(GRC); European Commission 793830; Neurology: Genetics; Vol. 6 (july 2020); https://ddd.uab.cat/record/231258; urn:10.1212/NXG.0000000000000484; urn:oai:ddd.uab.cat:231258; urn:pmcid:PMC7413607; urn:pmc-uid:7413607; urn:pmid:32802949; urn:oai:pubmedcentral.nih.gov:7413607; urn:oai:egreta.uab.cat:publications/4c570949-0785-4a96-891d-822114fbfffd

  18. 18
    Academic Journal

    المصدر: Jönsson , Å L M , Bendstrup , E , Mogensen , S , Kopras , E J , McCormack , F X , Campo , I , Mariani , F , Escribano-Montaner , A , Holm , A M , Martinez-Colls , M D M , Pintos-Morell , G , Taillé , C , Crestani , B , Hilberg , O , Hvarregaard Christensen , J & Simonsen , U 2020 , ' Eight novel variants in the SLC34A2 gene in pulmonary alveolar microlithiasis ' , European Respiratory Journal , vol. 55 , no. 2 . https://doi.org/10.1183/13993003.00806-2019

    وصف الملف: application/pdf

  19. 19
  20. 20
    Academic Journal

    وصف الملف: application/pdf

    Relation: Drug Design, Development and Therapy; Vol. 13 (2019), p. 3705-3715; https://ddd.uab.cat/record/223995; urn:10.2147/DDDT.S207856; urn:oai:ddd.uab.cat:223995; urn:scopus_id:85075481040; urn:articleid:11778881v13p3705; urn:pmid:31749608; urn:pmc-uid:6819672; urn:pmcid:PMC6819672; urn:oai:pubmedcentral.nih.gov:6819672; urn:oai:egreta.uab.cat:publications/276e9897-6996-4c9d-873a-f5071e651781